Fernandez-Fuertes, MMacías, JCorma-Gómez, ARincón, PMerchante, NGómez-Mateos, JPineda, J AReal, L M2023-02-082023-02-082020-04-21http://hdl.handle.net/10668/15407Hepatic steatosis (HS) is frequently observed in HIV-infected patients. It is not known whether HIV infection is an independent risk factor for HS development. We aimed to analyze whether HIV coinfection was associated with a higher frequency of HS in patients with chronic hepatitis C. This was a retrospective cross-sectional study. 574 subjects with chronic hepatitis C virus (HCV) infection were included, 246 (43%) of them coinfected with HIV. All of them underwent transient elastography with controlled attenuation parameter (CAP) measurement. HS was defined as CAP ≥ 248 dB/m. 147 individuals (45%) showed HS in the HCV-monoinfected group and 100 (40.7%) in the HIV/HCV-coinfected group (p = 0.318). HS was associated with body mass index (BMI) [enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Body Mass IndexCholesterol, HDLCholesterol, LDLCoinfectionCross-Sectional StudiesElasticity Imaging TechniquesFatty LiverFemaleHIVHIV InfectionsHepacivirusHepatitis C, ChronicHumansLiverMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsSpainTriglyceridesresearch article32317646open access10.1038/s41598-020-62671-y2045-2322PMC7174281https://www.nature.com/articles/s41598-020-62671-y.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174281/pdf